Value proposition

Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-care diagnostics. With a vision focused on universalizing access to precise, rapid and cost-effective healthcare technologies, Molbio is at the forefront of providing cutting-edge solutions for quality healthcare delivery at the last mile by decentralizing and democratizing diagnostics through its advanced portable platforms. Renowned for its WHO-endorsed Truenat® real-time PCR platform, and an ever-growing basket of tests, Molbio empowers remote, resource-poor settings worldwide to implement sophisticated diagnostics for infectious diseases like TB and hepatitis to non-communicable diseases such as breast cancer, sickle cell disease, diabetes, and more.

Molecular Diagnostics, TB Diagnostic Tools, Point of care testing, Portable Multi Disease RT-PCR, Ultra Portable Handheld X-Ray, Breast Cancer Screening with AI, TRUENAT, PRORAD, and portable healthcare diagnostic solutions